← Latest Filings

F

Foresite Capital Management V, LLC

Also a 13F filer: see its fund portfolio and quarterly moves →

Open-market buys

8

$13.6M total

Open-market sells

0

$0 total

Tracking since

Nov 2025

Activity timeline

Open-market buy — $2.5M

Latigo Biotherapeutics, Inc. · Aug 10, 2026

Open-market buy — $1000K

Eikon Therapeutics, Inc. · Feb 4, 2026

Open-market trades from the last two years.

Holdings as last reported

3,414,544 Common Stock in LTGO

Held indirectly (See Footnote) · as of 2026-08-10

Companies touched

Latigo Biotherapeutics, Inc.